DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability
暂无分享,去创建一个
Sergio Alonso | Masaaki Saito | T. Rikiyama | M. Perucho | F. Konishi | Manuel Perucho | Koichi Suzuki | S. Alonso | Fumio Konishi | Takaharu Kato | F. Watanabe | Yuta Muto | T. Maeda | H. Kamiyama | Masaaki Saito | K. Koizumi | Y. Miyaki | Koichi Suzuki | Yuta Muto | Takafumi Maeda | Takaharu Kato | Fumiaki Watanabe | Hidenori Kamiyama | Kei Koizumi | Yuichiro Miyaki | Toshiki Rikiyama | Yuichiro Miyaki
[1] M. Wiesmann,et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] Tsung-Teh Wu,et al. Frequent CpG island methylation in serrated adenomas of the colorectum. , 2003, The American journal of pathology.
[3] Teruhiko Yoshida,et al. The genomic damage estimated by arbitrarily primed PCR DNA fingerprinting is useful for the prognosis of gastric cancer. , 2003, Gastroenterology.
[4] H. Bouzourène,et al. Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? , 2007, Virchows Archiv.
[5] K. Togashi,et al. Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent manner. , 2011, Experimental and therapeutic medicine.
[6] S. Baylin,et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. , 1999, Cancer research.
[7] K. Batts,et al. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. , 2005, American journal of clinical pathology.
[8] M. Perucho,et al. DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer. , 2010, Mutation research.
[9] David I. Smith,et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling (vol 26, pg 146, 2000) , 2000 .
[10] Yan Peng,et al. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms , 2012, Journal of Clinical Pathology.
[11] M. Perucho,et al. Microsatellite instability: The mutator that mutates the other mutator , 1996, Nature Medicine.
[12] Kentaro Yamashita,et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. , 2006, Cancer cell.
[13] I. Forgacs. GASTROENTEROLOGY , 1988, The Lancet.
[14] R. Genta,et al. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients , 2010, Journal of Clinical Pathology.
[15] Frequent p53 gene mutations in serrated adenomas of the colorectum , 1998, The Journal of pathology.
[16] S. Takada,et al. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability , 2006, Oncogene.
[17] Hiroyuki Yamamoto,et al. Gastrointestinal cancer of the microsatellite mutator phenotype pathway , 2002, Journal of Gastroenterology.
[18] M. Perucho,et al. DNA demethylation in normal colon tissue predicts predisposition to multiple cancers , 2012, Oncogene.
[19] M. Perucho,et al. Array-based identification of common DNA methylation alterations in ulcerative colitis , 2011, International journal of oncology.
[20] T. Sekiya,et al. NotI‐MseI methylation‐sensitive amplified fragment length polymorphism for DNA methylation analysis of human cancers , 2001, Electrophoresis.
[21] Mari Mino-Kenudson,et al. Sessile Serrated Adenoma: Challenging Discrimination From Other Serrated Colonic Polyps , 2008, The American journal of surgical pathology.
[22] B. Leggett,et al. Role of the serrated pathway in colorectal cancer pathogenesis. , 2010, Gastroenterology.
[23] K. Kaneko,et al. No major tumorigenic role for β-catenin in serrated as opposed to conventional colorectal adenomas , 2003, British Journal of Cancer.
[24] J. Jass,et al. My approach to serrated polyps of the colorectum , 2004, Journal of Clinical Pathology.
[25] David K. Driman,et al. Sessile Serrated Adenoma (SSA) vs. Traditional Serrated Adenoma (TSA) , 2008, The American journal of surgical pathology.
[26] M. O'brien,et al. Comparison of Microsatellite Instability, CpG Island Methylation Phenotype, BRAF and KRAS Status in Serrated Polyps and Traditional Adenomas Indicates Separate Pathways to Distinct Colorectal Carcinoma End Points , 2006, The American journal of surgical pathology.
[27] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[28] C. Fenoglio-Preiser,et al. Mixed Hyperplastic Adenomatous Polyps/Serrated Adenomas: A Distinct Form of Colorectal Neoplasia , 1990, The American journal of surgical pathology.
[29] A I Saeed,et al. TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.
[30] M. O'brien,et al. BRAF and KRAS Mutations in Hyperplastic Polyps and Serrated Adenomas of the Colorectum: Relationship to Histology and CpG Island Methylation Status , 2004, The American journal of surgical pathology.
[31] Wei Zhao,et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. , 2003, Cancer research.
[32] E. J. Lee,et al. Progressive methylation during the serrated neoplasia pathway of the colorectum , 2005, Modern Pathology.
[33] R. Ward,et al. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma , 2009, Journal of Clinical Pathology.
[34] Wei Hsu,et al. The Mouse Fused Locus Encodes Axin, an Inhibitor of the Wnt Signaling Pathway That Regulates Embryonic Axis Formation , 1997, Cell.
[35] J. Herman,et al. CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[36] H. Toda,et al. Genetic Alterations of Mixed Hyperplastic Adenomatous Polyps in the Colon and Rectum , 1998, Japanese journal of cancer research : Gann.
[37] N. Matsubara,et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum , 2004, Gut.
[38] David I. Smith,et al. Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas , 2002, Oncogene.
[39] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[40] M. Toyota,et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein–Barr virus , 2006, Cancer.
[41] J. Benhattar,et al. Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps , 2009, Histopathology.
[42] T. Sugai,et al. Serrated Adenoma of the Colorectum Undergoes a Proliferation versus Differentiation Process: New Conceptual Interpretation of Morphogenesis , 2008, Oncology.
[43] Darryl Shibata,et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.
[44] Jahn M. Nesland,et al. Morphologic Reappraisal of Serrated Colorectal Polyps , 2003, The American journal of surgical pathology.
[45] W. Grady. CIMP and colon cancer gets more complicated , 2007, Gut.
[46] D. Aust,et al. Serrated polyps of the colon and rectum (hyperplastic polyps, sessile serrated adenomas, traditional serrated adenomas, and mixed polyps)—proposal for diagnostic criteria , 2010, Virchows Archiv.
[47] M. O'brien,et al. Hyperplastic (Serrated) Polyps of the Colorectum: Relationship of CpG Island Methylator Phenotype and K-ras Mutation to Location and Histologic Subtype , 2004, The American journal of surgical pathology.
[48] R. Dehari,et al. Infrequent APC mutations in serrated adenoma. , 2001, The Tohoku journal of experimental medicine.
[49] E. Torlakovic,et al. Serrated adenomatous polyposis in humans. , 1996, Gastroenterology.
[50] F. Konishi,et al. Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer. , 2011, International journal of oncology.
[51] M. Toyota,et al. CIMP, at last. , 2005, Gastroenterology.
[52] R. Lothe,et al. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. , 2005, Neoplasia.
[53] M. Loda,et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. , 1997, Cancer research.
[54] M. Perucho,et al. Genetics supersedes epigenetics in colon cancer phenotype. , 2003, Cancer cell.
[55] R. Fodde,et al. Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability , 2010, Genes, chromosomes & cancer.
[56] S. Kakar,et al. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps , 2008, International journal of cancer.
[57] Peter W. Laird,et al. Interplay between the Cancer Genome and Epigenome , 2013, Cell.
[58] P. Laird,et al. COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.
[59] Hans Clevers,et al. Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors , 2002, Molecular and Cellular Biology.